Feedback / Questions
EMP-01 - atai Life Sci
https://www.globenewswire.com/news-release/2025/05/13/3079966/0/en/atai-Life-Sciences-Announces-First-Patient-Dosed-in-Phase-2-Study-of-EMP-01-for-the-Treatment-of-Social-Anxiety-Disorder.html
May 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next